MYC and cancer: While MYC oncoproteins provide an attractive target for cancer therapy because of their frequent somatic activation and the addiction that MYC-driven tumors have to these oncoproteins (reviewed in Gabay et al. [15]), they have been difficult to directly inhibit pharmacologically [7,16].